Epstein-Barr virus genomes are found predominantly in IgA-positive B cells in the blood of healthy carriers

International Journal of Cancer

Volumn 83, Issue 1, 1999, Pages 50-54

  Ehlin Henriksson, Barbro ^a   Zou, Jie Zhi ^a   Klein, George ^a   Ernberg, Ingemar ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS DNA;

ARTICLE; B LYMPHOCYTE; DNA DETERMINATION; EPSTEIN BARR VIRUS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS CARRIER; VIRUS DETECTION; VIRUS GENOME; VIRUS LOAD;

B-LYMPHOCYTES; CELL FRACTIONATION; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; FLOW CYTOMETRY; GENOME, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PHENOTYPE; POLYMERASE CHAIN REACTION; VIRAL MATRIX PROTEINS; VIRUS LATENCY;

EID: 0032840441     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990924)83:1<50::AID-IJC10>3.0.CO;2-1     Document Type: Article

References (25)

1. ANDERSSON, M., Amounts of Epstein-Barr virus DNA in somatic cell hybrids between Burkitt lymphoma derived cell lines. J. Virol., 16, 1345-1347 (1975).
2. BABCOCK, G.J., DECKER, L.L., VOLK, M. and THORLEY-LAWSON, D.A., EBV persistence in memory B cells in vivo. Immunity, 9, 395-404 (1998).
3. BIRX, D.L., REDFIELD, R.R. and TOSATO, G., Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders. N. Engl. J. Med., 314, 874-879 (1986).
4. CHEN, F., ZOE, J.Z., DI RENZO, L., WINBERG, G., HU, L.F., KLEIN, E., KLEIN, G. and ERNBERG, I., A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1. J. Virol, 69, 3752-3758 (1995).
5. ERNBERG, I., The role of Epstein-Barr virus in lymphomas of homosexual males. Progr. Allergy, 37, 301-318 (1986).
6. GRATAMA, J.W., OOSTERVEER, M.A., ZWAAN, F.E., LEPOUTRE, J., KLEIN, G. and ERNBERG, I., Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency. Proc. nat. Acad. Sci. (Wash.), 85, 8693-8696 (1988).
7. HINUMA, Y., KONN, M., YAMAGUCHI, J. and GRACE, J.T., JR., Replication of herpes-type virus in a Burkitt lymphoma cell line. J. Virol., 1, 1203-1206 (1967).
8. HOLMGREN, L., SZELES, A., RAJINAVÖLGYI, E., FOLKMAN, J., KLEIN, G. and FALK, K., Horizontal transfer of Epstein-Barr virus DNA by the uptake of apoptotic bodies. Blood (1999). (In press).
9. KHAN, G., MIYASHITA, E.M., YANG, B., BABCOCK, G.J. and THORLEY-LAWSON, D.A., Is EBV persistence in vivo a model for B cell homeostasis? Immunity, 5, 173-179 (1996).
10. KLEIN, G., Epstein-Barr virus, malaria and Burkitt lymphoma. Scand. J. infect. Dis. (Suppl. 36), 15-23 (1982).
11. LAM, K.M.C., WHITTLE, H., GRZYWACS, M. and CRAWFORD, D.H., Epstein-Barr virus-carrying B cells are large, surface IgM, IgD-bearing cells in normal individuals and acute malaria patients. Immunology, 82, 383-388 (1994).
12. LEWIN, N., ÅMAN, P., MASUCCI, M.G., KLEIN, E., KLEIN, G., ÖBERG, B., STRANDBERG, H., HENLE, W. and HENLE, G., Characterization of EBV-carrying B-cell populations in healthy seropositive individuals with regard to density, release of transforming virus and spontaneous outgrowth. Int. J. Cancer, 39, 472-476 (1987).
13. MARKLUND, G., ERNBERG, I., LUNDBERG, C., HENLE, W. and HENLE, G., Differences in EBV-specific antibody pattern at onset of infectious mononucleosis. Scand. J. infect. Dis., 18, 25-32 (1986).
14. MASUCCI, M.G. and ERNBERG, I., Epstein-Barr virus: adaptation to a life within the immune system. Trends Microbiol., 2, 125-130 (1994).
15. MIYASHITA, E.M., YANG, B., LAM, D., CRAWFORD, D. and THORLEY-LAWSON, D.A., A novel form of Epstein-Barr virus latency in normal B cells in vivo. Cell, 80, 593-601 (1995).
16. NIEDOBITEK, G., YOUNG, L.S., LAU, R., BROOKS, L., GREENSPAN, D., GREENSPAN, J.S. and RICKINSON, A.B., Epstein-Barr virus infection in oral hairy leukoplacia: virus replication in the absence of a detectable latent phase. J. gen. Virol., 72, 3035-3046 (1991).
17. NILSSON, K., High frequency-establishment of human immunoglobulin producing lymphoblastoid lines from normal and malignant lymphoid tissue and peripheral blood. Int. J. Cancer, 8, 432-442 (1971).
18. PAULY, J.L., MINOVADA, J., HAN, T. and MOORE, G.E., Disparity of mixed lymphocyte reactivity to cultured cells of human T and B lymphoid lines. J. nat. Cancer Inst., 54, 557-562 (1975).
19. QU, L. and ROWE, D.T., Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes. J. Virol. 66, 3715-3724 (1992).
20. REED, L.J. and MUENCH, H., A simple method of estimation fifty per cent endpoints. Ann. J. Hyg., 27, 493-497 (1938).
21. RICKINSON, A.B., FINERTY, S. and EPSTEIN, M., Comparative studies on adult donor lymphocytes infected by EB virus in vitro or in vivo: origin of transformed cells arising in co-cultures with fetal lymphocytes. Int. J. Cancer, 19, 775-782 (1977).
22. TIERNEY, R.J., STEVENS, N., YOUNG, L.S. and RICKINSON, A.B., Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. J. Virol., 68, 7374-7385 (1994).
23. TSUKUDA, K., VOLSKY, D.J., SHAPIRO, I.M. and KLEIN, G., Epstein-Barr virus (EBV) receptor implantation onto human B lymphocytes changes immunoglobulin secretion pattern induced by EBV infection. Europ. J. Immunol., 12, 87-90 (1982).
24. WALDMAN, H., COBBOLD, S. and LEFKOVTS, I., Limited dilution analysis. In: G.G.B. Klaus (ed.), Lymphocytes: a practical approach, pp. 163-188, IRL Press, Oxford (1987).
25. YAO, Q.Y., ROWE, M., MARTIN, B., YOUNG, L.S. and RICKINSON, A.B., The Epstein-Barr virus carrier state: dominance of a single growth-transforming isolate in the blood and in the oropharynx of healthy virus carriers. J. gen. Virol., 72, 1579-1590 (1991).